Monitor 14-Drug Class Profile (LabCorp MedWatch®) – 764422

Amphetamine; barbiturates; benzodiazepines; buprenorphine; cocaine (and metabolite); creatinine; fentanyl; meperidine; methadone; opiate; oxycodone/oxymorphone; pH; phencyclidine (PCP); propoxyphene; specific gravity; tetrahydrocannabinol (THC); tramadol. Note: Contains expanded benzodiazepine confirmation upon reflex of positive screen. Positive expanded benzodiazepine screen includes alpha-hydroxy-alprazolam, alpha-hydroxy-midazolam, alpha-hydroxy-triazolam, 7-aminoclonazepam, hydroxy-ethyl-flurazepam, lorazepam, nordiazepam, oxazepam, and temazepam. Opiate confirmation of positive screen includes hydrocodone, hydromorphone, codeine, and morphine.